Physician profile
Donna Page
NPI 1336164706
$1,171.36
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $187 · 2021: $215 · 2022: $149 · 2023: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $197.87 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $135.03 | 2019-2023 | Vaxneuvance, M-M-R II, Rotateq |
| Ironshore Pharmaceuticals INC. | $101.37 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.85 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $90.50 | 2022-2023 | Flumist Quadrivalent |
| Pfizer INC. | $76.76 | 2020-2023 | |
| Corium, LLC | $63.74 | 2022-2023 | Azstarys |
| Biogen, INC. | $63.34 | 2020-2021 | |
| Sanofi Pasteur INC. | $62.34 | 2021-2023 | |
| Cranial Technologies, INC | $50.99 | 2020-2022 | |
| Philips North America LLC | $37.59 | 2019 | |
| Seqirus USA INC | $30.91 | 2021-2023 | Flucelvax Quadrivalent |
| Neos Therapeutics, Lp | $30.61 | 2022 | |
| Adlon Therapeutics L.P. | $30.03 | 2020 | |
| Verrica Pharmaceuticals INC. | $23.90 | 2023 | Ycanth |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $20.48 | 2021 | |
| Sanofi-Aventis U.S. LLC | $18.14 | 2023 | |
| Rhodes Pharmaceuticals L.P. | $15.00 | 2019 | |
| Phadia US INC. | $13.96 | 2019 | |
| Kaleo, INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.